BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1283763)

  • 1. Carbohydrate metabolism, insulin resistance, and metabolic cardiovascular syndrome.
    Vaaler S
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S11-4. PubMed ID: 1283763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins, lipases, and the metabolic cardiovascular syndrome.
    Blomhoff JP
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S22-5. PubMed ID: 1283765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin resistance].
    Arteaga Llona A
    Rev Med Chil; 1993 Feb; 121(2):197-8. PubMed ID: 8303118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in type II diabetes mellitus.
    Rizza R; Butler P
    Adv Second Messenger Phosphoprotein Res; 1990; 24():511-6. PubMed ID: 2169826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
    Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
    Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduced glucose tolerance as a risk factor of cardiovascular diseases].
    Holmen J
    Tidsskr Nor Laegeforen; 1994 Jun; 114(15):1700-3. PubMed ID: 8079281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
    Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes.
    Robert JJ; Magre J; Reynet C; Darmaun D; Picard J; Capeau J
    Diabete Metab; 1990; 16(3):240-7. PubMed ID: 2210020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease.
    Reaven GM
    Diabete Metab; 1991 May; 17(1 Pt 2):78-86. PubMed ID: 1936488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal fat distribution and the metabolic syndrome.
    Björntorp P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S26-8. PubMed ID: 1283766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and insulin resistance: perioperative considerations.
    Bagry HS; Raghavendran S; Carli F
    Anesthesiology; 2008 Mar; 108(3):506-23. PubMed ID: 18292688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance in liver diseases].
    Petrides AS; Strohmeyer G
    Z Gastroenterol; 1986 Aug; 24(8):403-15. PubMed ID: 3532594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.